Tandem Diabetes Care, Inc. (TNDM)
USD 16.43
(-6.96%)
USD 16.43
(-6.96%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 356.79 Million USD | 44.24% |
| 2022 | 247.36 Million USD | 1.59% |
| 2021 | 243.48 Million USD | 82.11% |
| 2020 | 133.7 Million USD | 534.22% |
| 2019 | -30.79 Million USD | 26.38% |
| 2018 | -41.82 Million USD | -166.56% |
| 2017 | 62.84 Million USD | 83.31% |
| 2016 | 34.28 Million USD | 355.47% |
| 2015 | -13.41 Million USD | -672.98% |
| 2014 | -1.73 Million USD | 98.17% |
| 2013 | -94.98 Million USD | -632.96% |
| 2012 | -12.95 Million USD | -408.58% |
| 2011 | 4.19 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 418.57 Million USD | 17.31% |
| 2024 Q2 | 429.41 Million USD | 2.59% |
| 2023 Q4 | 356.79 Million USD | 5.38% |
| 2023 Q3 | 338.59 Million USD | 16.95% |
| 2023 FY | 356.79 Million USD | 44.24% |
| 2023 Q1 | 292.63 Million USD | 18.3% |
| 2023 Q2 | 289.53 Million USD | -1.06% |
| 2022 FY | 247.36 Million USD | 1.59% |
| 2022 Q4 | 247.36 Million USD | -17.06% |
| 2022 Q1 | 325.49 Million USD | 33.68% |
| 2022 Q3 | 298.23 Million USD | -2.89% |
| 2022 Q2 | 307.1 Million USD | -5.65% |
| 2021 FY | 243.48 Million USD | 82.11% |
| 2021 Q2 | 218.65 Million USD | 10.53% |
| 2021 Q1 | 197.83 Million USD | 47.96% |
| 2021 Q4 | 243.48 Million USD | 19.59% |
| 2021 Q3 | 203.59 Million USD | -6.89% |
| 2020 Q4 | 133.7 Million USD | 37.99% |
| 2020 Q3 | 96.89 Million USD | 49286.29% |
| 2020 Q1 | -46.61 Million USD | -51.4% |
| 2020 Q2 | -197 Thousand USD | 99.58% |
| 2020 FY | 133.7 Million USD | 534.22% |
| 2019 Q4 | -30.79 Million USD | -23.91% |
| 2019 Q3 | -24.85 Million USD | -53.33% |
| 2019 FY | -30.79 Million USD | 26.38% |
| 2019 Q1 | -26.05 Million USD | 37.7% |
| 2019 Q2 | -16.2 Million USD | 37.8% |
| 2018 Q3 | -32.32 Million USD | -221.75% |
| 2018 Q4 | -41.82 Million USD | -29.38% |
| 2018 FY | -41.82 Million USD | -166.56% |
| 2018 Q1 | 13.82 Million USD | -78.0% |
| 2018 Q2 | 26.55 Million USD | 92.1% |
| 2017 FY | 62.84 Million USD | 83.31% |
| 2017 Q4 | 62.84 Million USD | -1.06% |
| 2017 Q1 | 33.42 Million USD | -2.49% |
| 2017 Q3 | 63.51 Million USD | 34.21% |
| 2017 Q2 | 47.32 Million USD | 41.57% |
| 2016 Q1 | 3.49 Million USD | 126.05% |
| 2016 FY | 34.28 Million USD | 355.47% |
| 2016 Q4 | 34.28 Million USD | 28.28% |
| 2016 Q3 | 26.72 Million USD | 88.9% |
| 2016 Q2 | 14.14 Million USD | 304.69% |
| 2015 FY | -13.41 Million USD | -672.98% |
| 2015 Q4 | -13.41 Million USD | 2.09% |
| 2015 Q3 | -13.7 Million USD | 16.64% |
| 2015 Q2 | -16.44 Million USD | 50.31% |
| 2015 Q1 | -33.09 Million USD | -1806.11% |
| 2014 Q1 | -47.38 Million USD | 50.12% |
| 2014 FY | -1.73 Million USD | 98.17% |
| 2014 Q4 | -1.73 Million USD | 71.74% |
| 2014 Q3 | -6.14 Million USD | 82.36% |
| 2014 Q2 | -34.81 Million USD | 26.52% |
| 2013 Q1 | 17.16 Million USD | 232.43% |
| 2013 Q2 | -841.02 Thousand USD | -104.9% |
| 2013 Q3 | 13.79 Million USD | 1740.65% |
| 2013 Q4 | -94.98 Million USD | -788.41% |
| 2013 FY | -94.98 Million USD | -632.96% |
| 2012 FY | -12.95 Million USD | -408.58% |
| 2012 Q4 | -12.95 Million USD | 0.0% |
| 2011 FY | 4.19 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | -1217.477% |
| BrainsWay Ltd. | -10.32 Million USD | 3557.355% |
| Cerus Corporation | 84.35 Million USD | -322.988% |
| Envoy Medical, Inc. | -3.81 Million USD | 9454.982% |
| electroCore, Inc. | -9.95 Million USD | 3684.119% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 7061.932% |
| IceCure Medical Ltd | -9.93 Million USD | 3691.695% |
| Inogen, Inc. | -103.56 Million USD | 444.504% |
| OrthoPediatrics Corp. | -9.26 Million USD | 3950.21% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 9899.478% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 2824.272% |
| MaxCyte, Inc. | -27.76 Million USD | 1385.16% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 7044.191% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 62069.338% |
| Orthofix Medical Inc. | 96.44 Million USD | -269.962% |
| PAVmed Inc | 29.08 Million USD | -1126.704% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 2206.376% |
| RxSight, Inc. | -6.68 Million USD | 5441.302% |
| Sight Sciences, Inc. | -102.71 Million USD | 447.368% |
| SI-BONE, Inc. | 5.72 Million USD | -6136.654% |
| TELA Bio, Inc. | -3.94 Million USD | 9135.173% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | -522.458% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | -101263.352% |
| Acutus Medical, Inc. | 12.27 Million USD | -2805.766% |
| Talis Biomedical Corporation | -57.06 Million USD | 725.261% |
| Spectral AI, Inc. | -3.5 Million USD | 10291.345% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 842.913% |
| CVRx, Inc. | -59.95 Million USD | 695.101% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | -17882.506% |
| PetVivo Holdings, Inc. | 1.27 Million USD | -27826.477% |
| Bioventus Inc. | 372.51 Million USD | 4.218% |
| Venus Concept Inc. | 74.3 Million USD | -380.208% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 3604.213% |
| LivaNova PLC | 62.53 Million USD | -470.586% |
| 908 Devices Inc. | -115.09 Million USD | 410.001% |
| Alphatec Holdings, Inc. | 320.7 Million USD | -11.253% |
| Nemaura Medical Inc. | 9.92 Million USD | -3494.946% |
| NeuroPace, Inc. | 54.33 Million USD | -556.641% |
| LENSAR, Inc. | -18.31 Million USD | 2048.444% |
| Apyx Medical Corporation | -5.15 Million USD | 7026.791% |
| Cutera, Inc. | 288.3 Million USD | -23.76% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | -4647.824% |
| BioSig Technologies, Inc. | 262 Thousand USD | -136082.824% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 914.052% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 3978.672% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 74.61% |
| Axonics, Inc. | -77.19 Million USD | 562.211% |
| Outset Medical, Inc. | 67.67 Million USD | -427.193% |
| IRIDEX Corporation | -4.28 Million USD | 8420.872% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 300.429% |
| IRadimed Corporation | -47.71 Million USD | 847.706% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 11891.11% |
| INVO Bioscience, Inc. | 8.45 Million USD | -4121.905% |
| Telesis Bio, Inc. | 32.63 Million USD | -993.302% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 14359.799% |
| Varex Imaging Corporation | 316.9 Million USD | -12.59% |
| Quipt Home Medical Corp. | 81.73 Million USD | -336.534% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 12925.27% |
| Pulmonx Corporation | -42.36 Million USD | 942.302% |
| Dynatronics Corporation | 6.2 Million USD | -5651.082% |
| Modular Medical, Inc. | -8.04 Million USD | 4536.695% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 8403.444% |
| Semler Scientific, Inc. | -57.13 Million USD | 724.539% |
| InMode Ltd. | -135.39 Million USD | 363.526% |
| Bruker Corporation | 891.3 Million USD | 59.969% |
| Cytosorbents Corporation | 4.18 Million USD | -8431.748% |
| DexCom, Inc. | 2.02 Billion USD | 82.404% |
| Align Technology, Inc. | -840.47 Million USD | 142.452% |
| Viveve Medical, Inc. | -13.81 Million USD | 2683.067% |
| ZimVie Inc. | 450.41 Million USD | 20.785% |
| Movano Inc. | -5.86 Million USD | 6182.492% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 365.365% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 62069.338% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | -17882.506% |
| Profound Medical Corp. | -18.17 Million USD | 2062.751% |
| Insulet Corporation | 798.1 Million USD | 55.294% |
| enVVeno Medical Corporation | -2.21 Million USD | 16186.519% |
| Surmodics, Inc. | -12.01 Million USD | 3069.86% |
| iCAD, Inc. | -21.2 Million USD | 1782.3% |
| Nuwellis, Inc. | -2.81 Million USD | 12756.935% |
| Biotricity, Inc. | 23.09 Million USD | -1445.071% |
| iRhythm Technologies, Inc. | 93.65 Million USD | -280.988% |
| Aethlon Medical, Inc. | -4.5 Million USD | 8025.939% |
| InspireMD, Inc. | -8.04 Million USD | 4535.04% |
| PAVmed Inc. | 29.08 Million USD | -1126.704% |
| BIOLASE, Inc. | 11.34 Million USD | -3045.266% |
| Beyond Air, Inc. | 6.22 Million USD | -5628.03% |
| FONAR Corporation | -14.66 Million USD | 2532.943% |
| AxoGen, Inc. | 32.26 Million USD | -1005.805% |
| Vivani Medical, Inc. | 42 Thousand USD | -849421.429% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 3447.711% |
| Inari Medical, Inc. | -7.16 Million USD | 5082.53% |
| UFP Technologies, Inc. | 40.77 Million USD | -775.065% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | -11527.329% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 7578.009% |
| Tenon Medical, Inc. | -1.25 Million USD | 28530.199% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 4791.02% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 3091.696% |
| AdaptHealth Corp. | 2.21 Billion USD | 83.91% |
| Sintx Technologies, Inc. | 905 Thousand USD | -39325.304% |
| NanoVibronix, Inc. | -3.27 Million USD | 10984.655% |
| Quanterix Corporation | -132.95 Million USD | 368.355% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 12925.27% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 1695.345% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 52.662% |
| TransMedics Group, Inc. | 121.13 Million USD | -194.549% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 1462.869% |
| NeuroMetrix, Inc. | -1.49 Million USD | 24029.058% |
| Hyperfine, Inc. | -75.61 Million USD | 571.838% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | -134.445% |
| Biomerica, Inc. | -3.38 Million USD | 10640.591% |
| Bone Biologics Corporation | -3.02 Million USD | 11888.894% |
| AVITA Medical, Inc. | -26.23 Million USD | 1460.187% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | 19508.011% |
| Silk Road Medical, Inc | 64.42 Million USD | -453.838% |